Dexelance S.p.A. (BIT:DEX)
Italy · Delayed Price · Currency is EUR 6.80
0.00 (0.00%)
Aug 14, 2025, 11:39 AM CET
Revance Therapeutics Market Cap
Dexelance has a market cap or net worth of €181.39 million as of August 14, 2025. Its market cap has decreased by -31.81% in one year.
Market Cap
181.39M
Enterprise Value
300.45M
Revenue
326.16M
Ranking
n/a
PE Ratio
11.58
Stock Price
$6.80
Market Cap Chart
Since May 18, 2023, Dexelance's market cap has decreased from 301.57M to 181.39M, a decrease of -39.85%. That is a compound annual growth rate of -20.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 181.39M | -23.26% |
| Dec 30, 2024 | 236.38M | -13.75% |
| Dec 29, 2023 | 274.06M | -9.12% |
| May 18, 2023 | 301.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ferrari | 67.79B |
| Stellantis | 23.17B |
| Moncler | 12.49B |
| Brunello Cucinelli | 6.57B |
| Lottomatica Group | 6.03B |
| Pirelli & C. | 5.78B |
| De'Longhi | 4.44B |
| Technogym | 2.86B |